News About: Pharm. Industry
Drugmakers, wholesalers raise voices against new drug-pricing system
Concerns are mounting in both drug manufacturers and wholesalers over the contentious financial incentive system designed to grant cash rewards to doctors or pharmacists that would purchase medicines as cheaply as pos...
Teva-Handok to start operations in mid-October
The Teva-Handok business venture is expected to commence activities in the middle of this month.
Last December, Teva Pharmaceutical Industries and Handok Pharmaceutical announced their agreement to establish a busi...
Propecia celebrates 15 years of birth
It has been 15 years since Propecia (finasteride), Merck’s popular hair loss medication, which has sold more than 2.7 billion tablets in 50 countries, was released.
If all those were laid end-to-end, the total dis...
Lutronic inks deal to buy US medical equipment company
Lutronic Inc., the country's leading innovator of aesthetic and medical advanced laser and related technology, said Tuesday it has reached a deal to buy a U.S.-based medical equipment firm to expand its overseas marke...
Pharmaceutical industry striving to shrug off “rebate” image
The pharmaceutical industry has never really had a good reputation, either here or elsewhere. Behind the life-curing business are heavy lobbying, dirty politics and giant rebates for favorite buyers, all of which is r...
Government urged to use Korean name “off-patent drug”
The Korea Pharmaceutical Manufacturers Association (KPMA) will ask for the Ministry of Health and Welfare and the Ministry of Food and Drug Safety to use the Korean name “off-patent drug” instead of “generic drug” to ...
Drug firms to hire more rookies in October
October is expected to be the most crucial season for job hunters, as major pharmaceutical firms have announced their recruitment plans as they are spurring efforts to overcome the blunt of the government’s forced pri...
Wholesalers grapping to boost bottom lines
All eyes are on the movement of the Pharmaceutical Development Conference (PDC) as Bayer Korea expressed its internal decision to cut wholesalers’ profit margins by 5 percent next year, during a meeting with executive...
Wholesalers to boycott Bayer Korea products
Local drug wholesalers will join a nationwide campaign to boycott Bayer Korea’s medicines to protest the company’s policy to cut the current wholesalers’ profit margins.
Bayer Korea and the Korea Pharmaceutical Who...
R&D spending of local drugmakers and medical device manufacturers on the rise
Korean companies producing medicines and medical devices have been spending more on research and development (R&D) projects to strengthen their technology leadership.
The Korea Health Industry Development Institute...
